The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Achillion Pharmaceuticals Inc | COM | 00448Q201 | 1,458 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
| Aeglea BioTherapeutics | COM | 00773J103 | 38 | 6,000 | SH | SOLE | 6,000 | 0 | 0 | ||
| Akari Therapeutics Plc | COM | 00972G108 | 1,348 | 158,352 | SH | SOLE | 158,352 | 0 | 0 | ||
| Alcobra Ltd | COM | M2239P109 | 1,628 | 658,910 | SH | SOLE | 658,910 | 0 | 0 | ||
| ARCA biopharma Inc | COM | 00211Y100 | 1,309 | 462,399 | SH | SOLE | 462,399 | 0 | 0 | ||
| Ascendis Pharma A/S | COM | 04351P101 | 1,809 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
| Adverum Biotechnologies | COM | 00773U108 | 4,532 | 1,102,735 | SH | SOLE | 1,102,735 | 0 | 0 | ||
| Audentes Therapeutics | COM | 05070R104 | 267 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
| Axovant Sciences Ltd | COM | G0750W104 | 2,578 | 184,110 | SH | SOLE | 184,110 | 0 | 0 | ||
| BioCryst Pharmaceuticals Inc | COM | 09058V103 | 4,433 | 1,005,104 | SH | SOLE | 1,005,104 | 0 | 0 | ||
| BeiGene Ltd | COM | 07725L102 | 1,571 | 51,000 | SH | SOLE | 51,000 | 0 | 0 | ||
| Coherus Biosciences Inc | COM | 19249H103 | 8,181 | 305,505 | SH | SOLE | 305,505 | 0 | 0 | ||
| CoLucid Pharmaceuticals | COM | 19716T101 | 2,601 | 68,190 | SH | SOLE | 68,190 | 0 | 0 | ||
| CytomX Therapeutics Inc | COM | 23284F105 | 1,007 | 64,200 | SH | SOLE | 64,200 | 0 | 0 | ||
| DBV Technologies | COM | F2927N109 | 32,492 | 456,893 | SH | SOLE | 456,893 | 0 | 0 | ||
| Edge Therapeutics Inc | COM | 279870109 | 1,405 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | ||
| Flamel Technologies S.A. | COM | 338488109 | 6,200 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| Heron Therapeutics Inc | COM | 427746102 | 18,879 | 1,095,734 | SH | SOLE | 1,095,734 | 0 | 0 | ||
| Lipocine Inc | COM | 53630X104 | 3,791 | 849,921 | SH | SOLE | 849,921 | 0 | 0 | ||
| Ocera Therapeutics | COM | 67552A108 | 2,261 | 856,550 | SH | SOLE | 856,550 | 0 | 0 | ||
| ProNAI Therapeutics Inc | COM | 74346L101 | 102 | 56,056 | SH | SOLE | 56,056 | 0 | 0 | ||
| REGENXBIO Inc | COM | 75901B107 | 337 | 24,089 | SH | SOLE | 24,089 | 0 | 0 | ||
| Stemline Therapeutics Inc | COM | 85858C107 | 1,467 | 135,420 | SH | SOLE | 135,420 | 0 | 0 | ||
| Zafgen Inc | COM | 98885E103 | 1,993 | 602,114 | SH | SOLE | 602,114 | 0 | 0 | ||